Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yoko Inaguma

Showing results (21-30 of 22) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 22 results.
Blood|September 2, 2017
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDSIsao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, et al.
Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.
Pageof 3

Showing results (21-30 of 22) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 22 results.
Blood|September 2, 2017
Safety and persistence of WT1-specific T-cell receptor gene-transduced lymphocytes in patients with AML and MDSIsao Tawara, Shinichi Kageyama, Yoshihiro Miyahara, et al.
Cancer Science|February 12, 2021
Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapyNobuhiko Yamauchi, Dai Maruyama, Ilseung Choi, et al.
Pageof 3